Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (NVO)
NYSE:NVO
Cagrilintide
Obesity, Overweight
Phase III
Not Yet Recruiting
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
Oct 23, 2025
―
Cagrilintide
Type 2 Diabetes, Obesity, Overweight
Phase III
Not Yet Recruiting
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Oct 23, 2025
―
Nnc0442-0344 A
Haemophilia A
Phase I
Not Yet Recruiting
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Oct 22, 2025
―
Nnc0537-1482
Heart Failure
Phase I
Not Yet Recruiting
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
Oct 16, 2025
―
Nnc4005-001
Fatty Liver Disease
Phase I
Not Yet Recruiting
A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat
Oct 06, 2025
―
Nnc6019-0001
Transthyretin Amyloid Cardiomyopathy (Attr Cm)
Phase III
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Sep 23, 2025
―
Nnc0662-0419
Obesity, Overweight
Phase II
Recruiting
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
Sep 18, 2025
―
Cagrisema (Cagrilintide B + Semaglutide I), Low Energy Diet
Obesity
Phase I
Recruiting
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
Sep 13, 2025
―
Eptacog Alfa (Novoseven)
Severe Postpartum Haemorrhage
Phase IV
Recruiting
A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India
Aug 19, 2025
―
Nnc0487-0111 A
Obesity, Overweight
Phase I
Recruiting
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.
Aug 07, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Novo Nordisk (NVO) have in its pipeline
NVO is currently developing the following drugs: Cagrilintide, Cagrilintide, Nnc0442-0344 A. These drug candidates are in various stages of clinical development as the company works toward FDA approval.